Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 14 May 2025Pause in use of live-attenuated chikungunya vaccine in older adults due to safety concernsTopic: Chikungunya virus infection
  • 25 Apr 2025WHO reaffirms mpox outbreak in Africa still meets criteria for a public health emergency of international concernTopic: Mpox
  • 24 Apr 2025Dapagliflozin approved by FDA for treatment of type 2 diabetes in childrenTopic: Type 2 diabetes in children
  • 15 Apr 2025Latest UK asthma guidance provides minimal change to exacerbation managementTopic: Acute asthma exacerbation in adults
  • 19 Mar 2025Esketamine approved in the US as the first ever monotherapy for treatment-resistant depression in adultsTopic: Depression in adults
  • 14 Mar 2025Guidelines recommend statins for people living with HIV to prevent cardiovascular eventsTopic: HIV in adults
  • 14 Mar 2025NICE recommends cytisinicline for smoking cessation, expanding treatment options for clinicians in the UKTopic: Smoking cessation
  • 05 Mar 2025FDA approves olezarsen for the treatment of familial chylomicronemia syndromeTopic: Hypertriglyceridaemia
  • 18 Feb 2025Gene-editing therapy, exagamglogene autotemcel, available through managed access agreement in National Health Service (NHS) EnglandTopic: Sickle cell anaemia
  • 11 Feb 2025First bird flu death reported in the US outbreak; case of human infection detected in the UKTopic: Avian influenza A (H5N1) virus infection
  • 17 Jan 2025WHO recommends first single-dose drug for Plasmodium vivax malariaTopic: Malaria
  • 04 Dec 2024FDA grants approval of seladelpar, expanding options for second-line treatmentTopic: Primary biliary cholangitis
  • 19 Nov 2024WHO recommends fexinidazole for rhodesiense HATTopic: African trypanosomiasis
  • 15 Nov 2024FDA approves palopegteriparatide for hypoparathyroidism in adultsTopic: Hypoparathyroidism
  • 15 Nov 2024Clinicians urged to consider parvovirus B19 in people with fever, myalgia, arthralgia, and rash, after US and Europe report increased casesTopic: Erythema infectiosum